Trexquant Investment LP Kronos Bio, Inc. Transaction History

Trexquant Investment LP

  • $6.33 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$3.12 - $7.52 $143,526 - $345,935
-46,002 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$6.26 - $14.42 $287,972 - $663,348
46,002 New
46,002 $333,000
Q4 2021

Feb 14, 2022
SELL
$11.35 - $21.18 $112,387 - $209,724
-9,902 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$18.17 - $24.7 $179,919 - $244,579
9,902 New
9,902 $208,000

Others Institutions Holding KRON

# of Institutions
59
Shares Held
20.7M
Call Options Held
31.4K
Put Options Held
0
View Full List

About Kronos Bio, Inc.

KRON Quotes by TradingView
  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $53.4M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email